CABERGOLINE

Clinical Indication

Parkinson's disease

Comments

For new patients, existing patients to remain on therapy.

Date of classification

October 2021

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety